The shared-stock question: why contaminant screening matters before two colleagues rely on one batch

Laboratory stock is often shared quietly: one colleague orders a research material, another uses part of it for a related in-vitro study, and the paperwork is assumed to follow. That assumption becomes risky when the material is a lyophilised research peptide or preparation tool supplied for research-use-only work. The useful question is not simply “Is it the same product?” but “What was tested, which batch does the certificate describe, and can both colleagues prove the storage and handling history?” Materials discussed here are not for human or veterinary use, consumption, administration or clinical application.

Headline purity is a starting point, not a contaminant profile

A catalogue entry may lead with a purity figure because it is easy to compare. Research Sciences currently publishes statements about high purity and batch-level analytical verification, including HPLC purity and identity testing, and its FAQs describe a certificate of analysis for every product. Those statements are useful entry points, but they are not a substitute for opening the batch-specific CoA and checking what was actually screened. If a colleague quotes a headline such as ≥99% purity from the live site or a product page, that wording should be reconfirmed against the current published information and, more importantly, against the CoA that accompanies the vial in hand.

For shared stock, ask for the tests rather than only the banner claim. The relevant questions are whether the CoA supports identity, purity, and the contaminant checks described for the material, and whether the document belongs to the batch or delivery being shared. Research Sciences describes full-spectrum testing as purity, identity, heavy metals and endotoxin evaluation, and the homepage lists “CoAs Janoshik Analytical Reports”. Treat those as shop-published descriptions to verify on the live site and on the specific CoA, not as a reason to assume every vial has an identical evidence pack. A purity number without identity confirmation and documented contaminant screening can leave two colleagues sharing an assumption rather than a traceable stock.

There is also a documentation nuance for restocks. The FAQs state that restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. If two colleagues hold vials from different deliveries, the same product name and the same headline purity are not enough. Vial labels use a reference format combining SKU code and expiry, for example BPC10-03/27, and that reference should be quoted when contacting the shop about documentation. Vial cap colours and other packaging details may vary, but cap colour is not an indicator of identity, analytical quality or manufacturing origin.

What two colleagues should ask before sharing the same stock

Before one bench accepts another colleague’s stock, define “same stock” at batch and document level. The first questions are practical: which product and SKU are involved, what reference appears on the label, which CoA or ITR is being cited, and has the stock remained in the stated storage conditions? A materials manager should ask for the CoA reference and storage history before agreeing that a shared vial can support two in-vitro workstreams. If the stock has already been opened, record when it was opened and whether any laboratory reconstitution has taken place. Reconstitution should be discussed only as part of an in-vitro laboratory workflow, with diluent volume and concentration recorded for the assay; Research Sciences materials and any associated calculator are not for medical or clinical use.

The evidence pack should be checked against the tests, not only the label. Does the CoA let both colleagues see identity and purity information, and does it address the contaminant screening associated with the batch? If the documentation is unclear, the product reference should be taken back to the supplier for clarification rather than inferred from a website headline. The purchaser remains responsible for lawful use, safe handling, storage and disposal, and for compliance with relevant UK requirements including COSHH and laboratory safety standards. It is also the purchaser’s responsibility to check that the material is suitable for the intended research application.

Shared stock can create small formulation and handling problems too. Research Sciences states that peptides contain trace amounts of mannitol, and that it does not supply blended peptides, recommending that researchers buy peptides individually and combine only within a controlled experimental design. If two colleagues plan different assays, they should confirm that the same stock can be used without unplanned blending or protocol drift. Allow vials to reach room temperature before opening, work in a clean environment, and remove only the amount required. Store lyophilised peptides at −20°C or below, sealed with desiccant and protected from moisture, heat and light; avoid repeated freeze–thaw cycles. Reconstituted peptides are less stable and should be kept at 2–8°C for short-term laboratory use. These are handling notes for research-use-only materials, not for human or veterinary use.

Storage, dispatch and a shared-stock audit trail

A shared-stock register should connect the paperwork to the physical vial. Record the product and SKU, label reference and expiry, CoA or ITR reference, quantity received and remaining, storage location, receipt month, opening entries, and any laboratory reconstitution or freeze–thaw history. This is not bureaucracy for its own sake: it lets a second colleague see which evidence applies to the material being used and whether the stock has moved outside its stated conditions. When reviewing current catalogue entries, researchers can compare products through Buy peptides and then open the individual product page and CoA for batch-specific documentation; the listing description alone is not a batch record. All items remain research-use-only and are not for human or veterinary use.

Fulfilment records also matter for shared stock planning. Research Sciences publishes next-working-day dispatch, with Royal Mail Tracked 24 usually delivering the following working day as an estimate, and the homepage “24hr UK Delivery” line should not be read as a guaranteed arrival promise. Tracked UK dispatch and temperature-aware storage are described, but delivery times may vary in peak periods. The shop also states that returns are not accepted once dispatched because of the specialist and perishable nature of the goods, with refunds limited to damage, incorrect supply or quality issues under its policy. Those terms should be reconfirmed at checkout and not stretched into assumptions about replacement stock or delivery certainty.

For two colleagues sharing one stock, the final control is simple: the CoA reference, ITR note and storage log should be available before use, and any ambiguity should be resolved with the supplier before the material enters a study. Keep the lyophilised stock sealed with desiccant at −20°C or below, protect it from light, moisture and heat, and record every removal. If a shared stock cannot produce the label reference, the CoA trail and the storage history, it is not yet a documented shared stock; it is a shared assumption.